BioPhorum Supply Chain to Patient

BioPhorum Supply Chain to Patient is developing resilient and agile supply chains that consistently deliver high-quality medicines to patients. Our members are working to create a transparent patient-centric, end-to-end supply chain to ensure an uninterrupted supply to our patients through industry collaboration.

The biopharmaceutical industry plays a crucial role in delivering life-saving medications, vaccines, and therapies to patients worldwide, however the current outbound supply chain, designed around a blockbuster model, no longer suits the evolving pipeline and emerging modalities. Recent challenges, including the COVID-19 pandemic, geopolitical events, ultra-low-temperature transport, and environmental concerns tied to new sustainability regulations, underline the need for a more agile, resilient, cost-effective, patient-centric supply chain. The complex nature of the outbound supply chain necessitates industry collaboration amongst biopharmaceutical manufacturers, 3Pls, and partner organizations to make a meaningful change.

To meet the demands of the future, the supply chain must undergo a continuous evolution, striving for greater agility and adaptability, all while maintaining strict regulatory compliance and minimizing our ecological footprint.

Are you ready to become a member? Make an enquiry today.


During the development of a Strategic Framework that spotlights five key objectives for a successful supply chain, several areas for collaboration have been acknowledged. With a need for greater industry benchmarking, the team is developing a maturity tool to assess a company’s supply chain against the framework’s five objectives. The data will then be used to develop business cases for investment, drive focus, and benchmark against peers.

Standardization, particularly for cell and gene therapy products, will allow for a more agile supply chain. Engaging with patients at the start of a transformation is crucial to enable the industry to build a patient-centric supply chain. By inviting regulators, and healthcare providers to collaborate we can drive innovation within the supply chain and refine processes in areas such as direct-to-patient shipping.

The potential to propel the biopharma supply chain forward into the future is vast.

The Strategic Framework is a reference for the biopharmaceutical industry, enabling organizations to align with industry trends, reassess their priorities, and plan future developments. BioPhorum Supply Chain to Patient will use the Framework objectives to evaluate its program and ensure alignment with industry goals, fostering focused collaboration:

  • Data-driven decision-making: fully digital integrated supply chain enabled by accurate real-time information
  • Uninterrupted, cost-effective, agile supply chain: ensuring continuity of supply in an adaptable and cost-effective manner
  • Sustainable and responsible: sustainable supply chain with minimized impact on the planet
  • Dynamic and skilled workforce: diverse workforce supported by ongoing training and development opportunities
  • Drive innovation through collaboration: engaging with regulators, healthcare and patients to drive innovation and industry collaboration.

Contact BioPhorum Supply Chain to Patient

To find out more about how BioPhorum BioPhorum Supply Chain to Patient can help your business, enter your details below and a member of our team will be in touch.

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.


BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.


Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Resilience

Supply Resilience is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.


Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
Digital Plant Maturity Model 3.0
Inaugural BioPhorum Quality face to face – get involved
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
A launchpad for an improved CGT outbound supply chain
DNA and Earth on blue background
A vision for the biopharmaceutical industry’s inbound supply chain
Building a resilient business means adopting water stewardship
Technology Roadmap V 2.0
BioPhorum Technology Roadmapping roadmap vision 2.0


Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.


Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.


BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.


A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

Bioreactivity testing in single-use system biomanufacturing
Bioreactivity testing in single-use system biomanufacturing
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
Digital Plant Maturity Model 3.0
Bioreactivity testing in single-use system biomanufacturing